Pharmaceutical Glass Packaging Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Pharmaceutical Glass Packaging Market
The pharmaceutical glass packaging market size was valued at USD 6.31 billion in 2019, and the market is now projected to grow USD 10.76 billion in 2027, exhibiting a CAGR of 6.3% during the forecast period of 2024-2027.
The lockdown and stay-home orders that continued for many months all over the globe disrupted many industries, although the pharmaceutical industries were least affected since they are essential industries. Manufacturers of drugs and packaging firms received an exemption from the limitations of lock down to ensure uninterrupted production of healthcare products. To ensure they continue to meet their customers’ needs while at the same time limiting human contact that can spread coronavirus infections, packaging companies stepped up their use of technologies such as robotizing processes. These measures helped the industry continue its level of productivity and meet basic health care needs. Covid-19 brought into focus the issue of the business continuity of pharmaceutical supply chains.
The pharma major continents such as China and India along with the developed countries like Brazil, the United States, United Kingdom, and Germany etc are adding more heath conscious population and hence boosting the overall growth of the pharma industry. Growth of this sector is rising the consumption of glass packaging material because of its resolvability, transparency, and chemical stability. The latter owes to several advantages of glass packaging such as moisture and air tightness, and the possibility to sterilize the material. Modern technologies and improvements of performance in the manufacturing industry are also pushing the consumption of glass in the industry. These elements allow presenting glass packaging as one of the solutions appropriate for satisfying the increasing needs of the pharmaceutical sector.
Other factors about the glass health include the need for pharmaceutical glass packaging due to the advancement in boron-free glass such as Valor by Corning Inc. Specifically, boron free glass eliminates boron volatilization, thus stabilize glass matrix and provide chemical durability throughout the substrate with minimal problems such as glass flake formation as seen in conventional glasses. They include the use of permanent engraving where manufactures are using it as a measure to reduce counterfeiting thus increasing the market for it. These innovations mean that carrying new technology into pharmaceutical packaging is going to improve the quality and reliability of the packaging being delivered. Therefore, new-generation glasses have a significant potential in managing the new requirements of the pharmaceutical sector.
Comprehensive Analysis of Pharmaceutical Glass Packaging Market
The pharmaceutical glass packaging market growth is rising at an exponential rate due to its market segmentation. This market expansion rightly presents a detailed local analysis based on the forces such as supply and demand which define the industry. These segmentations are methodically segregated by product analysis, and by drug type analysis. By product analysis include vials & ampoules, bottles, cartridges, and syringes. By drug type analysis include generic, branded, and biologic.
The North America region lead the pharmaceutical glass packaging market share by benefitting a market size of USD 2.12 billion in 2019 due to its increasing spending on healthcare.
The top players have a significant responsibility in the chemicals & advanced materials industry for confirming industrial prospectus growth and determining the market trends. These players include, Corning Inc., Nipro Corporation, SCHOTT, Gerresheimer AG, SGD S.A., Stölzle-Oberglas GmbH, Bormioli Pharma, West Pharmaceutical Services, Inc., Shandong Medicinal Glass Co., Ltd., Beatson Clark, and Şişecam Group these market players provide a level-playing competitive landscape.
In May 2021, Nipro Pharma Corporation signed a contract with AstraZeneca to manufacture over 90 million doses of the COVID-19 vaccine Vaxzevria in Japan.
Segmentation Table
ATTRIBUTES DETAILS
Study Period 2016-2027
Base Year 2019
Forecast Period 2020-2027
Historical Period 2016-2018
Unit Value (USD Billion)
Segmentation
By Product
Vials & Ampoules
Bottles
Cartridges
Syringes
By Drug Type
Generic
Branded
Biologic
By Geography
North America
By Product
By Drug Type
By Country
U.S. (By Drug Type)
Canada (By Drug Type)
Europe
By Product
By Drug Type
By Country
Germany (By Drug Type)
UK (By Drug Type)
France (By Drug Type)
Italy (By Drug Type)
Spain (By Drug Type)
Rest of Europe (By Drug Type)
Asia Pacific
By Product
By Drug Type
By Country
China (By Drug Type)
Japan (By Drug Type)
India (By Drug Type)
Rest of Asia Pacific (By Drug Type)
Latin America
By Product
By Drug Type
By Country
Brazil (By Drug Type)
Mexico (By Drug Type)
Rest of Latin America (By Drug Type)
Middle East & Africa
By Product
By Drug Type
By Country
GCC (By Drug Type)
Rest of Middle East & Africa (By Drug Type)
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market SegHouseholdtation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Key Market Trends in the Global Market
- 4.2. Key Developments: Mergers, Acquisition, Partnership, etc. .
- 4.3. Latest Technological Advancement
- 4.4. Insights on Regulatory Scenario
- 4.5. Porters Five Forces Analysis
- 5. Qualitative Insights Impact of COVID 19 on Global Pharmaceutical Glass Packaging Market
- 5.1. Supply Chain Challenges
- 5.2. Steps taken by Government/Companies to overcome this impact
- 5.3. Potential opportunities due to COVID-19 outbreak
- 6. Global Pharmaceutical Glass Packaging Market Analysis, Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Size Estimates and Forecast
- 6.2.1. By Product (Value)
- 6.2.1.1. Vials & Ampoules
- 6.2.1.2. Bottles
- 6.2.1.3. Cartridges
- 6.2.1.4. Syringes
- 6.2.2. By Drug Type (Value)
- 6.2.2.1. Generic
- 6.2.2.2. Branded
- 6.2.2.3. Biologic
- 6.2.3. By Region (Value)
- 6.2.3.1. North America
- 6.2.3.2. Europe
- 6.2.3.3. Asia Pacific
- 6.2.3.4. Latin America
- 6.2.3.5. Middle East & Africa
- 7. North America Pharmaceutical Glass Packaging Market Analysis, Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Size Estimates and Forecast
- 7.2.1. By Product (Value)
- 7.2.1.1. Vials & Ampoules
- 7.2.1.2. Bottles
- 7.2.1.3. Cartridges
- 7.2.1.4. Syringes
- 7.2.2. By Drug Type (Value)
- 7.2.2.1. Generic
- 7.2.2.2. Branded
- 7.2.2.3. Biologic
- 7.2.3. By Country (Value)
- 7.2.3.1. U.S
- 7.2.3.2. Canada
- 8. Europe Pharmaceutical Glass Packaging Market Analysis, Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Size Estimates and Forecast
- 8.2.1. By Product (Value)
- 8.2.1.1. Vials & Ampoules
- 8.2.1.2. Bottles
- 8.2.1.3. Cartridges
- 8.2.1.4. Syringes
- 8.2.2. By Drug Type (Value)
- 8.2.2.1. Generic
- 8.2.2.2. Branded
- 8.2.2.3. Biologic
- 8.2.3. By Country (Value)
- 8.2.3.1. Germany
- 8.2.3.2. France
- 8.2.3.3. U.K.
- 8.2.3.4. Italy
- 8.2.3.5. Spain
- 8.2.3.6. Rest of Europe
- 9. Asia-Pacific Pharmaceutical Glass Packaging Market Analysis, Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Size Estimates and Forecast
- 9.2.1. By Product (Value)
- 9.2.1.1. Vials & Ampoules
- 9.2.1.2. Bottles
- 9.2.1.3. Cartridges
- 9.2.1.4. Syringes
- 9.2.2. By Drug Type (Value)
- 9.2.2.1. Generic
- 9.2.2.2. Branded
- 9.2.2.3. Biologic
- 9.2.3. By Country (Value)
- 9.2.3.1. China
- 9.2.3.2. Japan
- 9.2.3.3. India
- 9.2.3.4. Rest of Asia-Pacific
- 10. Latin America Pharmaceutical Glass Packaging Market Analysis, Insights and Forecast, 2016-2027
- 10.1. Key Findings / Summary
- 10.2. Market Size Estimates and Forecast
- 10.2.1. By Product (Value)
- 10.2.1.1. Vials & Ampoules
- 10.2.1.2. Bottles
- 10.2.1.3. Cartridges
- 10.2.1.4. Syringes
- 10.2.2. By Drug Type (Value)
- 10.2.2.1. Generic
- 10.2.2.2. Branded
- 10.2.2.3. Biologic
- 10.2.3. By Country (Value)
- 10.2.3.1. Brazil
- 10.2.3.2. Mexico
- 10.2.3.3. Rest of Latin America
- 11. Middle East & Africa Pharmaceutical Glass Packaging Market Analysis, Insights and Forecast, 2016-2027
- 11.1. Key Findings / Summary
- 11.2. Market Size Estimates and Forecast
- 11.2.1. By Product (Value)
- 11.2.1.1. Vials & Ampoules
- 11.2.1.2. Bottles
- 11.2.1.3. Cartridges
- 11.2.1.4. Syringes
- 11.2.2. By Drug Type (Value)
- 11.2.2.1. Generic
- 11.2.2.2. Branded
- 11.2.2.3. Biologic
- 11.2.3. By Country (Value)
- 11.2.3.1. GCC
- 11.2.3.2. Rest of Middle East & Africa
- 12. Company Profiles
- 12.1. Corning Inc.
- 12.1.1. Overview
- 12.1.2. Description
- 12.1.3. Product Portfolio
- 12.1.4. Financials (Data as available in public domain and/or on paid databases)
- 12.1.5. Recent DevelopHouseholdts
- 12.2. Nipro Corporation
- 12.2.1. Overview
- 12.2.2. Description
- 12.2.3. Product Portfolio
- 12.2.4. Financials (Data as available in public domain and/or on paid databases)
- 12.2.5. Recent DevelopHouseholdts
- 12.3. SCHOTT
- 12.3.1. Overview
- 12.3.2. Description
- 12.3.3. Product Portfolio
- 12.3.4. Financials (Data as available in public domain and/or on paid databases)
- 12.3.5. Recent DevelopHouseholdts
- 12.4. Gerresheimer AG
- 12.4.1. Overview
- 12.4.2. Description
- 12.4.3. Product Portfolio
- 12.4.4. Financials (Data as available in public domain and/or on paid databases)
- 12.4.5. Recent DevelopHouseholdts
- 12.5. SGD S.A.
- 12.5.1. Overview
- 12.5.2. Description
- 12.5.3. Product Portfolio
- 12.5.4. Financials (Data as available in public domain and/or on paid databases)
- 12.5.5. Recent DevelopHouseholdts
- 12.6. Stölzle-Oberglas GmbH
- 12.6.1. Overview
- 12.6.2. Description
- 12.6.3. Product Portfolio
- 12.6.4. Financials (Data as available in public domain and/or on paid databases)
- 12.6.5. Recent DevelopHouseholdts
- 12.7. Bormioli Pharma
- 12.7.1. Overview
- 12.7.2. Description
- 12.7.3. Product Portfolio
- 12.7.4. Financials (Data as available in public domain and/or on paid databases)
- 12.7.5. Recent DevelopHouseholdts
- 12.8. West Pharmaceutical Services, Inc
- 12.8.1. Overview
- 12.8.2. Description
- 12.8.3. Product Portfolio
- 12.8.4. Financials (Data as available in public domain and/or on paid databases)
- 12.8.5. Recent DevelopHouseholdts
- 12.9. Shandong Medicinal Glass Co., Ltd.
- 12.9.1. Overview
- 12.9.2. Description
- 12.9.3. Product Portfolio
- 12.9.4. Financials (Data as available in public domain and/or on paid databases)
- 12.9.5. Recent DevelopHouseholdts
- 12.10. Beatson Clark
- 12.10.1. Overview
- 12.10.2. Description
- 12.10.3. Product Portfolio
- 12.10.4. Financials (Data as available in public domain and/or on paid databases)
- 12.10.5. Recent DevelopHouseholdts
- 12.11. Şişecam Group
- 12.11.1. Overview
- 12.11.2. Description
- 12.11.3. Product Portfolio
- 12.11.4. Financials (Data as available in public domain and/or on paid databases)
- 12.11.5. Recent DevelopHouseholdts
- 12.12. Other Key Players
- 12.12.1. Overview
- 12.12.2. Description
- 12.12.3. Product Portfolio
- 12.12.4. Financials (Data as available in public domain and/or on paid databases)
- 12.12.5. Recent DevelopHouseholdts
- 13. Strategic Recommendation
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook